Cointime

Precipio Diagnostics

company

About

Precipio Diagnostics is a cancer diagnostics reference laboratory delivering advanced diagnostics, advice and personalized medicine.

  • 1 - 10

Highlights

Total Funding Amount
$1.80M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series B
Last Funding Money Raised
$1.80M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.80M
Precipio Diagnostics has raised a total of $1.80M in funding over 2 rounds. Their latest funding was raised on Oct 28, 2013 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 28, 2013 Series B $1.80M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Precipio Diagnostics is funded by 2 investors. Advantage Capital and Eli Whitney Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Advantage Capital — Series B
Eli Whitney Fund — Series B
Cointime
Chủ Đề
Công Ty